Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories

Immune reactions in the tumor microenvironment are an important hallmark of cancer, and emerging immune therapies have been proven effective against several types of cancers. To investigate cancer genome-immune interactions and the role of immunoediting or immune escape mechanisms in cancer developm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2021-08, Vol.11 (1), p.15713-15713, Article 15713
Hauptverfasser: Mizuno, Shinichi, Yamaguchi, Rui, Hasegawa, Takanori, Hayashi, Shuto, Fujita, Masashi, Zhang, Fan, Koh, Youngil, Lee, Su-Yeon, Yoon, Sung-Soo, Shimizu, Eigo, Komura, Mitsuhiro, Fujimoto, Akihiro, Nagai, Momoko, Kato, Mamoru, Liang, Han, Miyano, Satoru, Zhang, Zemin, Nakagawa, Hidewaki, Imoto, Seiya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Immune reactions in the tumor microenvironment are an important hallmark of cancer, and emerging immune therapies have been proven effective against several types of cancers. To investigate cancer genome-immune interactions and the role of immunoediting or immune escape mechanisms in cancer development, we analyzed 2834 whole genome and RNA sequencing datasets across 31 distinct tumor types with respect to key immunogenomic aspects and provided comprehensive immunogenomic profiles of pan-cancers. We found that selective copy number changes in immune-related genes may contribute to immune escape. Furthermore, we developed an index of the immunoediting history of each tumor sample based on the information of mutations in exonic regions and pseudogenes and evaluated the immunoediting history of each tumor. Our immuno-genomic analyses of pan-cancers have the potential to identify a subset of tumors with immunogenicity and diverse backgrounds or intrinsic pathways associated with their immune status and immunoediting history.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-021-95287-x